NanoGroup S.A. (NNG.WA)

PLN 2.37

(-1.25%)

Operating Expenses Summary of NanoGroup S.A.

NanoGroup S.A.'s latest annual operating expenses in 2023 was 7.82 Million PLN , up 847.65% from previous year.
NanoGroup S.A.'s latest quarterly operating expenses in 2024 Q2 was 1.41 Million PLN , up 463.9% from previous quarter.
NanoGroup S.A. reported a annual operating expenses of 825.9 Thousand PLN in annual operating expenses 2022, down -75.57% from previous year.
NanoGroup S.A. reported a annual operating expenses of 3.38 Million PLN in annual operating expenses 2021, down -13.78% from previous year.
NanoGroup S.A. reported a quarterly operating expenses of 241 Thousand PLN for 2024 Q1, down -92.51% from previous quarter.
NanoGroup S.A. reported a quarterly operating expenses of 1.25 Million PLN for 2023 Q3, down -16.75% from previous quarter.

Annual Operating Expenses Chart of NanoGroup S.A. (2023 - 2015)

Historical Annual Operating Expenses of NanoGroup S.A. (2023 - 2015)

Year	Operating Expenses	Operating Expenses Growth
2023	7.82 Million PLN	847.65%
2022	825.9 Thousand PLN	-75.57%
2021	3.38 Million PLN	-13.78%
2020	3.92 Million PLN	91.92%
2019	2.04 Million PLN	-17.97%
2018	2.49 Million PLN	26.48%
2017	1.96 Million PLN	111.15%
2016	932.44 Thousand PLN	44.53%
2015	645.17 Thousand PLN	0.0%

Year	Operating Expenses	Operating Expenses Growth
2024 Q2	1.41 Million PLN	463.9%
2024 Q1	241 Thousand PLN	-92.51%
2023 Q3	1.25 Million PLN	-16.75%
2023 Q1	1.84 Million PLN	158.29%
2023 Q2	1.51 Million PLN	-18.11%
2023 FY	13.26 Million PLN	1506.18%
2023 Q4	3.21 Million PLN	155.82%
2022 Q2	2.52 Million PLN	503402.79%
2022 FY	825.9 Thousand PLN	-75.57%
2022 Q4	-3.16 Million PLN	-316.18%
2022 Q3	1.46 Million PLN	-42.08%
2022 Q1	-502.00 PLN	-100.01%
2021 Q1	-21.00 PLN	-100.0%
2021 Q2	2.66 Million PLN	12706438.1%
2021 FY	3.38 Million PLN	-13.78%
2021 Q3	-2.66 Million PLN	-200.0%
2021 Q4	3.38 Million PLN	226.68%
2020 Q2	467.42 Thousand PLN	4.44%
2020 Q1	447.55 Thousand PLN	-78.09%
2020 FY	3.92 Million PLN	91.92%
2020 Q4	4.08 Million PLN	478.19%
2020 Q3	-1.08 Million PLN	-331.13%
2019 Q2	-16.81 Million PLN	-195.99%
2019 Q1	17.52 Million PLN	570.01%
2019 FY	2.04 Million PLN	-17.97%
2019 Q3	-702.81 Thousand PLN	95.82%
2019 Q4	2.04 Million PLN	390.64%
2018 Q2	744.59 Thousand PLN	-8.82%
2018 Q3	-1.68 Million PLN	-326.47%
2018 FY	2.49 Million PLN	26.48%
2018 Q4	2.61 Million PLN	255.09%
2018 Q1	816.61 Thousand PLN	-60.22%
2017 Q2	390.73 Thousand PLN	-20.33%
2017 FY	1.96 Million PLN	111.15%
2017 Q3	-965.05 Thousand PLN	-346.99%
2017 Q1	490.46 Thousand PLN	0.0%
2017 Q4	2.05 Million PLN	312.7%
2016 FY	932.44 Thousand PLN	44.53%
2015 FY	645.17 Thousand PLN	0.0%

Peer Operating Expenses Comparison of NanoGroup S.A.

Name	Operating Expenses	Operating Expenses Difference
Bioceltix S.A.	15.38 Million PLN	49.127%
BIOTON S.A.	57.55 Million PLN	86.402%
Captor Therapeutics Spolka Akcyjna	79.91 Million PLN	90.207%
Mabion S.A.	59.52 Million PLN	86.851%
Molecure S.A.	31.73 Million PLN	75.334%
Pharmena S.A.	-32.76 Million PLN	123.887%
Poltreg S.A.	15.47 Million PLN	49.424%
Pure Biologics Spólka Akcyjna	29.14 Million PLN	73.145%
Ryvu Therapeutics S.A.	4.73 Million PLN	-65.189%
Synthaverse S.A.	26.35 Million PLN	70.302%
Urteste S.A.	5.96 Million PLN	-31.144%